Status:
COMPLETED
Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block vs Bupivacaine Alone for Hemodynamics Stability in Craniotomy
Lead Sponsor:
Ain Shams University
Conditions:
Dexmedetomidine
Craniotomy
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The investigator tested the effect of dexmedetomidine as an adjuvant to bupivacaine compared to bupivacaine alone in mean arterial pressure stability in adult patients undergoing craniotomy
Detailed Description
A) Preoperative settings: Complete history taking and full physical examination. Routine preoperative investigations was done to all patients including laboratory investigations (complete blood pictu...
Eligibility Criteria
Inclusion
- Patients aged from 18 to 65 years.
- Patients ASA I or II undergoing supratentorial elective planned craniotomies.
Exclusion
- Patients refused to participate in the study.
- Patients with cardiovascular diseases such as hypertension or low cardiac reserve.
- History or known allergy to the used local anesthetic or opioids.
- Patient could not understand a visual analog scale (VAS).
- Bleeding disorders.
- Evidence of local infection at site of injection. 7. Emergency craniotomy
Key Trial Info
Start Date :
March 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 10 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06951256
Start Date
March 10 2024
End Date
September 10 2024
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams university
Cairo, Egypt, Egypt, 11111